Stock Screener App

Frei -

Installieren

29.09

10.15% 2.68

after-market

Handel nachbörslich: 29.10 0.01 +0.03%

Arcutis Biotherapeutics Inc (ARQT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Arcutis Biotherapeutics Inc-Aktie (ARQT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.21% 129.86	105.40	129.50	99.22	81.50
Cost Of Revenue	11.80% 10.94	9.784	11.69	8.685	7.492
Selling, General, and Administrative	10.88% 82.14	74.08	-	-	-
Costs And Expenses	0.92% 113.43	114.49	111.12	90.69	96.11
Operating Income/Loss	280.76% 16.43	-9.089	18.39	8.526	-14.61
Nonoperating Income/Loss	-1.284	-	-	-	-
Income Tax Expense/Benefit	46.24% 0.136	0.093	0.47	0.08	0.342
Net Income/Loss	232.88% 15.01	-11.29	17.39	7.41	-15.89
Basic Average Shares	100.79K% 130.52	0.1294	0.343	127.62	127.00
Diluted Average Shares	104.95K% 135.90	0.1294	0.343	132.88	127.00
Basic Earnings Per Share	222.22% 0.11	-0.09	0.13	0.06	-0.13
Diluted Earnings Per Share	222.22% 0.11	-0.09	0.13	0.06	-0.13

TLX

$10.57

0.75%

RLAY

$17.31

1.47%

TNGX

$22.70

2.32%

VKTX

$27.38

7.50%

LEGN

$19.79

3.94%

ACAD

$19.70

2.31%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters